DocGo (NASDAQ:DCGO) Receives Buy Rating from Needham & Company LLC

Needham & Company LLC restated their buy rating on shares of DocGo (NASDAQ:DCGO) in a report published on Tuesday morning,Benzinga reports. Needham & Company LLC currently has a $3.00 target price on the stock.

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of DocGo in a research report on Monday, December 29th. Three analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, DocGo currently has a consensus rating of “Hold” and a consensus price target of $2.50.

DocGo Trading Up 20.1%

NASDAQ DCGO opened at $0.78 on Tuesday. DocGo has a 1-year low of $0.60 and a 1-year high of $2.88. The company has a market capitalization of $76.05 million, a price-to-earnings ratio of -0.42 and a beta of 0.95. The stock’s 50 day moving average is $0.77 and its two-hundred day moving average is $1.02.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in DCGO. Empowered Funds LLC increased its holdings in shares of DocGo by 14.6% in the fourth quarter. Empowered Funds LLC now owns 138,306 shares of the company’s stock valued at $121,000 after purchasing an additional 17,607 shares during the last quarter. Boothbay Fund Management LLC lifted its stake in shares of DocGo by 39.0% during the 4th quarter. Boothbay Fund Management LLC now owns 200,947 shares of the company’s stock worth $176,000 after buying an additional 56,413 shares during the last quarter. Bridgeway Capital Management LLC lifted its stake in shares of DocGo by 45.5% during the 4th quarter. Bridgeway Capital Management LLC now owns 539,306 shares of the company’s stock worth $473,000 after buying an additional 168,607 shares during the last quarter. Jain Global LLC bought a new stake in shares of DocGo during the 4th quarter worth about $70,000. Finally, Public Employees Retirement System of Ohio bought a new stake in shares of DocGo during the 4th quarter worth about $40,000. 56.44% of the stock is owned by institutional investors and hedge funds.

Key Headlines Impacting DocGo

Here are the key news stories impacting DocGo this week:

• Positive Sentiment: Q4 revenue beat and market reaction — DocGo reported Q4 revenue of $74.9M, above consensus, and shares reportedly jumped (~15%) on the topline beat and upbeat commentary. Investing.com: DocGo shares surge
• Positive Sentiment: 2026 guidance and strategic review — management set 2026 revenue guidance of $290M–$310M, reiterated a path to profitability and said it is exploring strategic alternatives, which could unlock value or lead to a sale/transaction. Seeking Alpha: 2026 guidance & strategic alternatives
• Positive Sentiment: Analyst support — Cantor Fitzgerald reaffirmed an “overweight” rating with a $3 PT and Needham & Company reaffirmed a “buy” with a $3 PT, signaling continued institutional bullishness despite volatility. Benzinga: Cantor/Needham coverage
• Neutral Sentiment: Stifel revises target down — Stifel cut its price target from $4.00 to $2.50 but kept a “buy” rating, reducing near-term upside expectations while remaining constructive. Benzinga: Stifel lowers target
• Neutral Sentiment: Earnings call / transcripts available — management discussed the quarter, guidance and strategic alternatives on the Q4 2025 call; read the transcript for color on margin timing and capital allocation. MSN: Q4 2025 earnings call transcript
• Negative Sentiment: Large EPS miss and profitability pressure — DocGo reported a substantial GAAP loss for the quarter (wide of consensus) and negative margins/ROE, which underscore near-term profitability risks despite revenue growth in some areas. MarketBeat: Q4 results overview
• Negative Sentiment: YoY revenue drop in core operations — the company noted Q4 revenue declined versus prior year primarily due to the wind-down of a legacy business line, contributing to mixed investor reaction and continued execution risk. BusinessWire: Q4 & FY2025 results

About DocGo

DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.